HPV vaccine recommendations by age: A survey of providers in federally qualified health centers.
HPV vaccine recommendations by age: A survey of providers in federally qualified health centers.
复制标题
DOI：
10.1080/21645515.2023.2181610
复制
发表时间：
2023-12-31
影响因子：
4.8
通讯作者：
中科院分区：
文献类型：
--
作者：
临床医生的建议仍然是提高HPV疫苗接种率的关键因素。在2021年10月至2022年7月期间，对在联邦合格卫生中心执业的临床医生进行了调查。临床医生被问到他们如何推荐9-10岁，11-12岁，13-18岁，19-26岁和27-45岁的患者接种HPV疫苗（强烈推荐，提供但不强烈推荐，仅在患者开始对话时讨论，或建议反对）。评估描述性统计量，并利用精确二项逻辑回归分析来检查与9-10岁患者中HPV疫苗接种建议相关的因素。受访者（n = 148）主要是女性（85%），年龄在30-39岁之间（38%），白色，非西班牙裔（62%），高级实践提供者（55%），家庭医学专业（70%），并在东北部执业（63%）。HPV疫苗接种的强烈建议因年龄而异：65%强烈建议9-10岁，94%为11-12岁，96%为13-18岁，82%为19-26岁，26%为27-45岁。与妇女健康/妇产科专业相比，家庭医学临床医生不太可能在9-10岁时推荐HPV疫苗接种（p = .03）。大约三分之二在联邦合格的卫生中心或安全网环境中执业的临床医生强烈建议在9-10岁开始HPV疫苗系列。需要进行更多的研究，以改善对年轻群体的建议。
Clinician recommendation remains a critical factor in improving HPV vaccine uptake. Clinicians practicing in federally qualified health centers were surveyed between October 2021 and July 2022. Clinicians were asked how they recommended HPV vaccination for patients aged 9–10, 11–12, 13–18, 19–26, and 27–45 y (strongly recommend, offer but do not recommend strongly, discuss only if the patient initiates the conversation, or recommend against). Descriptive statistics were assessed, and exact binomial logistic regression analyses were utilized to examine factors associated with HPV vaccination recommendation in 9–10-y-old patients. Respondents (n = 148) were primarily female (85%), between the ages of 30–39 (38%), white, non-Hispanic (62%), advanced practice providers (55%), family medicine specialty (70%), and practicing in the Northeast (63%). Strong recommendations for HPV vaccination varied by age: 65% strongly recommended for ages 9–10, 94% for ages 11–12, 96% for ages 13–18, 82% for age 19–26, and 26% for ages 27–45 y. Compared to Women’s Health/OBGYN specialty, family medicine clinicians were less likely to recommend HPV vaccination at ages 9–10 (p = .03). Approximately two-thirds of clinicians practicing in federally qualified health centers or safety net settings strongly recommend HPV vaccine series initiation at ages 9–10. Additional research is needed to improve recommendations in younger age groups.
登录
查看更多内容
影响因子：
3.7
作者：
Casey, Sharon M.;Jansen, Emily;Perkins, Rebecca B.
通讯作者：
Perkins, Rebecca B.
影响因子：
5.9
作者：
Kashani, Beeta M.;Tibbits, Melissa;Watanabe-Galloway, Shinobu
通讯作者：
Watanabe-Galloway, Shinobu
影响因子：
2.8
作者：
Brennan LP;Rodriguez NM;Head KJ;Zimet GD;Kasting ML
通讯作者：
Kasting ML
影响因子：
3.1
作者：
Goleman, Martha J.;Dolce, Millie;Morack, Jennifer
通讯作者：
Morack, Jennifer
影响因子：
7.2
作者：
Eckert, Linda O'Neal
通讯作者：
Eckert, Linda O'Neal